-
-
-
-
-
-
-
Sarepta completes confirmatory study for duchenne therapies, study misses primary endpoint
-
-
-
-
-
-
-
Sarepta Therapeutics to Announce Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Sarepta Therapeutics to Announce First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Tops Q3 EPS by 68c
-
-
-
-
-
-
-
Sarepta Therapeutics Announces Second Quarter 2024 Financial Results and Recent Corporate Developments
-
-
-
-
-
-
-
These 8 stocks are the latest additions to Mizuho's Top Picks list
-
-
-
-
-
-
-
Sarepta Therapeutics Announces Third Quarter 2023 Financial Results and Recent Corporate Developments
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

